Medprin Regenerative Medical Technologies Co., Ltd. (SHE:301033)

China · Delayed Price · Currency is CNY

47.53

-0.11 (-0.23%)

At close: Oct 19, 2026

Market Cap	3.18B -33.1%
Revenue (ttm)	400.85M +27.6%
Net Income	122.41M +30.6%
EPS	1.82 +28.0%
Shares Out	66.81M
PE Ratio	26.14
Forward PE	n/a
Dividend	0.70 (1.47%)
Ex-Dividend Date	Jun 1, 2026

Volume	688,000
Open	47.13
Previous Close	47.64
Day's Range	46.35 - 47.99
52-Week Range	44.88 - 92.00
Beta	-0.11
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 22, 2026

About SHE:301033

Medprin Regenerative Medical Technologies Co., Ltd. engages in the research and development, manufacture, and sale of implantable medical devices in China and internationally. The company offers artificial dura mater patches, craniofacial repair and fixation systems, and absorbable regenerative oxidation for neurosurgery meningeal repair, skull repair fixation and rapid hemostasis, etc. It also offers ReDura, a Synthetic Dural Substitute; NeoDura, a novel dural patch; Recranio, a Cranio-Maxillofacial repair system; and StypCel, an Absorbable He... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2008

Employees 447

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 301033

Full Company Profile

Financial Performance

In 2025, SHE:301033's revenue was 368.83 million, an increase of 32.46% compared to the previous year's 278.44 million. Earnings were 113.13 million, an increase of 43.47%.

Financial Statements